Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Manufactures pharmaceuticals for cardiovascular treatment, central nervous system, internal medicine drugs and oncology treatment

MSN Laboratories Pvt Ltd. is an Indian private company with domestic subsidiaries, that engages in research and development of pharmaceuticals.

Manufactures pharmaceuticals

Unichem Laboratories Ltd. is a pharmaceutical company, which engages in the manufacturing and marketing of pharmaceutical formulations. The firm offers its products that address relevant therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives, and pain management. It operates through India and Outside India geographical segments. The Outside India segment comprises of United States of America and others. The company was founded by Amrut Mody in 1944 and is headquartered in Mumbai, India.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. Its products include health function food, medical equipment, quasi-drugs, over-the-counter drugs, ethical drugs and recommended products such as Binosto effervescent tablet, Tobicom-S soft capsule, Levotension tablet and TobicomKid Q-10 chewable tablets. The company was founded by Noh Jong-Hyeong on September 16, 1955 and is headquartered in Seoul, South Korea.

Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

Part of Lunan Pharmaceutical Group Co., Ltd., Shandong New Time Pharmaceutical Co. Ltd. is a Chinese company located in Linyi that manufactures pharmaceutical products.

CIMEX Pharma AG, a subsidiary of Emirate of Abu Dhabi (United Arab Emirates), is a company headquartered in Binningen, Switzerland. The firm supplies generic pharmaceuticals.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

Shenyang Pharmaceutical New Technology Co., Ltd., established on 2002-07-23, Business scope includes new drugs,veterinary medicine,medical supplements,chemical reagent,test equipment,Medical Device Research,to develop,transfer,consultation service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Liaoning Keji Pharmaceutical Co., Ltd., established on 2001-12-24, Business scope includes licensed projects:tablet,hard capsule,Granules,small volume injection,API(Berbamine Hydrochloride),pill(big honey pill),Production of rubber paste;General project:Warehousing Services(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Lundbeck Pharmaceuticals Italy SpA manufacturer of active Pharmaceutical ingredients and cGMP Intermediates, provider of API development and production services. The company was founded in 1929 and is headquartered in Padova, Italy.